Cargando…
New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
BACKGROUND: Myasthenia gravis (MG) is an autoimmune disease that targets acetylcholine receptor (AChR) of the neuromuscular junction. New-onset MG after SARS-CoV-2 vaccination has rarely been reported. CASE PRESENTATION: We report about three patients who presented new-onset myasthenia gravis after...
Autores principales: | Fanella, Gaia, Baiata, Claudio, Candeloro, Elisa, Toscano, Gianpaolo, Colnaghi, Silvia, Mauri, Marco, Cariddi, Lucia Princiotta, Rebecchi, Valentina, Solazzo, Francesca, Banfi, Paola, Piatti, Marialuisa, Ferrarese, Carlo, Versino, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308404/ https://www.ncbi.nlm.nih.gov/pubmed/35870026 http://dx.doi.org/10.1007/s10072-022-06284-5 |
Ejemplares similares
-
Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19
por: Scopelliti, Giuseppe, et al.
Publicado: (2020) -
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021) -
An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023) -
Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab
por: Mimori, Masahiro, et al.
Publicado: (2022) -
The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis
por: Galassi, Giuliana
Publicado: (2022)